196 related articles for article (PubMed ID: 33152399)
1. MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose.
Booth J; Caillet V; Briggs A; Hardcastle N; Angelis G; Jayamanne D; Shepherd M; Podreka A; Szymura K; Nguyen DT; Poulsen P; O'Brien R; Harris B; Haddad C; Eade T; Keall P
Radiother Oncol; 2021 Feb; 155():131-137. PubMed ID: 33152399
[TBL] [Abstract][Full Text] [Related]
2. The first patient treatment of electromagnetic-guided real time adaptive radiotherapy using MLC tracking for lung SABR.
Booth JT; Caillet V; Hardcastle N; O'Brien R; Szymura K; Crasta C; Harris B; Haddad C; Eade T; Keall PJ
Radiother Oncol; 2016 Oct; 121(1):19-25. PubMed ID: 27650013
[TBL] [Abstract][Full Text] [Related]
3. MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.
Caillet V; Keall PJ; Colvill E; Hardcastle N; O'Brien R; Szymura K; Booth JT
Radiother Oncol; 2017 Jul; 124(1):18-24. PubMed ID: 28655454
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
5. Real-time 4D dose reconstruction for tracked dynamic MLC deliveries for lung SBRT.
Kamerling CP; Fast MF; Ziegenhein P; Menten MJ; Nill S; Oelfke U
Med Phys; 2016 Nov; 43(11):6072. PubMed ID: 27806589
[TBL] [Abstract][Full Text] [Related]
6. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®.
Troeller A; Garny S; Pachmann S; Kantz S; Gerum S; Manapov F; Ganswindt U; Belka C; Söhn M
Radiat Oncol; 2015 Feb; 10():51. PubMed ID: 25888786
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
10. Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.
Hewson EA; Nguyen DT; O'Brien R; Poulsen PR; Booth JT; Greer P; Eade T; Kneebone A; Hruby G; Moodie T; Hayden AJ; Turner SL; Hardcastle N; Siva S; Tai KH; Martin J; Keall PJ
Radiother Oncol; 2020 Oct; 151():234-241. PubMed ID: 32828839
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the robustness of 3-dimensional conformal technique with MLC position control into the planning target volume in stereotactic body radiotherapy for lung cancer.
Saito M; Sano N; Kuriyama K; Komiyama T; Marino K; Aoki S; Maehata Y; Saito R; Suzuki H; Shibata Y; Ueda K; Onishi H
Med Dosim; 2020 Spring; 45(1):e1-e5. PubMed ID: 31138512
[TBL] [Abstract][Full Text] [Related]
12. The development of a 4D treatment planning methodology to simulate the tracking of central lung tumors in an MRI-linac.
Al-Ward SM; Kim A; McCann C; Ruschin M; Cheung P; Sahgal A; Keller BM
J Appl Clin Med Phys; 2018 Jan; 19(1):145-155. PubMed ID: 29194940
[TBL] [Abstract][Full Text] [Related]
13. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
[TBL] [Abstract][Full Text] [Related]
14. On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization.
Leung RWK; Chan MKH; Chiang CL; Wong M; Blanck O
Radiat Oncol; 2020 May; 15(1):130. PubMed ID: 32471457
[TBL] [Abstract][Full Text] [Related]
15. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.
Liang X; Zheng D; Mamalui-Hunter M; Flampouri S; Hoppe BS; Mendenhall N; Li Z
Pract Radiat Oncol; 2019 Jan; 9(1):38-48. PubMed ID: 30138747
[TBL] [Abstract][Full Text] [Related]
16. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.
Tekatli H; Palacios MA; Schneiders FL; Haasbeek CJA; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2023 Oct; 187():109823. PubMed ID: 37516364
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
[TBL] [Abstract][Full Text] [Related]
19. Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy?
Ghandourh W; Batumalai V; Boxer M; Holloway L
J Med Radiat Sci; 2021 Sep; 68(3):298-309. PubMed ID: 33934559
[TBL] [Abstract][Full Text] [Related]
20. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.
Poulsen PR; Murtaza G; Worm ES; Ravkilde T; O'Brien R; Grau C; Høyer M; Keall P
Radiother Oncol; 2020 Mar; 144():93-100. PubMed ID: 31786423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
